Uveal Melanoma: Approaches to Management

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Uveal Melanoma: Approaches to Management

Uveal Melanoma: Approaches to Management Ernest Rand Simpson MD, FRCSC Background Choroidal melanoma is the most common primary human intraocular malignancy. The estimated incidence throughout North America is 6 to…

read more

Optic Neuritis

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Optic Neuritis

Optic Neuritis Iris Ben-Bassat Mizrachi MD Jonathan D. Trobe MD I. OVERVIEW The treatment of optic neuritis has been explored in several randomized clinical trials (RCTs).1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 In the Optic Neuritis…

read more

Amblyopia

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Amblyopia

Amblyopia Jonathan M. Holmes BM, BCh Michael X. Repka MD, MBA Raymond T. Kraker MSPH A number of multicenter randomized controlled trials (RCTs) and prospective observational studies have been conducted…

read more

Retinopathy of Prematurity (ROP)

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Retinopathy of Prematurity (ROP)

Retinopathy of Prematurity (ROP) Emmanuel Chang MD, PhD Antonio Capone MD 1st edition contributions from Anna Ells, MD, FRCS (C). Introduction and Background of Retinopathy of Prematurity Retinopathy of prematurity…

read more

Arterial Occlusive Disease

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Arterial Occlusive Disease

Arterial Occlusive Disease Jason Noble MD, FRCSC, DABO, Mark O. Baerlocher MD, FRCPC Background Although atherosclerotic vascular disease is primarily appreciated as the major contributor to systemic morbidity and mortality…

read more

Evidence-Based Ophthalmology: Clinical Trials and Beyond Retinal Detachment and Proliferative Vitreoretinopathy

Aug 2, 2016 by in OPHTHALMOLOGY Comments Off on Evidence-Based Ophthalmology: Clinical Trials and Beyond Retinal Detachment and Proliferative Vitreoretinopathy

Evidence-Based Ophthalmology: Clinical Trials and Beyond Retinal Detachment and Proliferative Vitreoretinopathy T. Mark Johnson MD FRCSC I. INTRODUCTION The management of rhegmatogenous retinal detachment has evolved over the last century…

read more
Get Clinical Tree app for offline access